Article
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
Strong Bullish
100.0
−100 Bearish
0
+100 Bullish
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Sentiment Signal
Strong Bullish
100.0
−100Neutral+100
More Like This